UBS Group’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
UBS Group's RXST Position: Q1 2026 in Review
UBS Group reduced its RxSight (RXST) stake by 62% in Q1 2026, selling an estimated $3.2M and leaving 239,456 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #5239.
UBS Group first reported a position in RXST in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.39M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- UBS Group held 239,456 shares of RxSight worth $1.48M as of Q1 2026.
- UBS Group sold 385,144 RxSight shares in Q1 2026, an estimated $3.2M.
- RxSight made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5239 holding.
- UBS Group first reported a position in RxSight in Q4 2021 and has held it in 17 quarters since.
- UBS Group's RxSight position peaked at $7.39M in Q4 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.